Today: 16 April 2026
DBS stock slips as Singapore’s top lender sets Feb 9 results date — what to watch
14 January 2026
1 min read

DBS stock slips as Singapore’s top lender sets Feb 9 results date — what to watch

SINGAPORE, Jan 14, 2026, 14:49 SGT — Regular session

  • DBS shares slipped 0.5% to S$58.19, following Tuesday’s close of S$58.47
  • Bank will release its full-year 2025 results before the market opens on Feb. 9
  • CEO Tan Su Shan warned of currency swings and advised investors to hedge their large U.S. dollar positions

Shares of DBS Group Holdings (DBSM.SI) edged down 0.5% to S$58.19 in mid-afternoon trade Wednesday. The bank confirmed it will release its full-year 2025 results before the Singapore market opens on Feb. 9. The stock fluctuated between S$58.03 and S$58.48 during the session.

The exchange notice arrives amid investor efforts to gauge how 2026 will shape bank profits, as interest-rate forecasts keep shifting. For lenders, the key variable remains the spread between loan yields and deposit costs — known in banking as the net interest margin.

DBS CEO Tan Su Shan urged clients to consider the currency angle in their trades. “If you have too much U.S. dollars, think about hedging,” she said this week at a DBS Private Bank outlook event, highlighting low funding costs in some Asian currencies, including Singapore’s SORA benchmark. Reuters

The broader market showed weakness. Singapore’s Straits Times Index slipped 0.1% during the session, based on delayed exchange figures.

The other major local banks showed mixed results. OCBC Bank slipped 0.1% to S$20.10, whereas United Overseas Bank climbed 0.5% to S$36.36.

DBS has been active in regional credit markets recently. On Tuesday, digital finance company Atome announced it had renewed and increased its syndicated debt facility to $345 million. DBS came on board as a mandated lead arranger and bookrunner. Andy Tan, Atome’s chief commercial officer, said the move puts the firm in a stronger position to back its “rapidly growing” loan portfolio. Reuters

DBS shareholders will zero in on the Feb. 9 figures for signs of loan growth, fee momentum, and any changes in credit costs amid shifting borrowing conditions in the region. Traders, meanwhile, will watch closely for new details on wealth activity, where flows can swing rapidly as currencies fluctuate.

The bank’s currency update carries weight, impacting both client positioning in its wealth division and the appetite for funding in Singapore dollars and other regional currencies. SORA — the Singapore Overnight Rate Average — remains the main benchmark for Singapore dollar interest rates.

But the setup works both ways. A swift rate drop can pinch margins, while a sluggish economy tends to boost bad-loan provisions. Neither impact becomes clear until results day, and the stock leaves almost no room for mistakes.

DBS will release its full-year results before the market opens on Feb. 9, a key moment that could steer investor sentiment on Singapore bank earnings for the coming quarter.

Stock Market Today

  • Top ASX Penny Stocks to Watch in April 2026: Argosy Minerals and Appen Limited
    April 16, 2026, 3:50 PM EDT. As the ASX approaches the 9,000 level, investors eye penny stocks for growth amid mixed market signals. Argosy Minerals (ASX: AGY), valued at A$123.47 million, turned profitable in 2025 with a net income of A$7.31 million, driven by one-off gains, though it remains pre-revenue and faces going concern doubts. Appen Limited (ASX: APX), with a market cap of A$406.05 million, trades 66.9% below estimated fair value despite ongoing losses and a negative return on equity. Both companies are debt-free and show prospects in lithium exploration and AI data services, respectively. These penny stocks present opportunities with higher risk, influenced by operational challenges and market volatility.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Fortescue share price closes higher after China’s record iron ore imports — what to watch next
Previous Story

Fortescue share price closes higher after China’s record iron ore imports — what to watch next

CapitaLand Investment stock flat as India data centre fund raise sharpens focus on Feb. 11 results
Next Story

CapitaLand Investment stock flat as India data centre fund raise sharpens focus on Feb. 11 results

Go toTop